{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:19:39Z","timestamp":1780449579678,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68642","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:59:41Z","timestamp":1725458381000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors"],"prefix":"10.7759","author":[{"given":"Pavel","family":"Sorokin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Kulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Nikiforchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ulrikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-003801","article-title":"Proportions and incidence of locally advanced cervical cancer: a global systematic literature review","volume":"32","author":"Monk BJ","year":"2022","unstructured":"Monk BJ, Tan DS, Hern\u00e1ndez Chag\u00fci JD, Takyar J, Paskow MJ, Nunes AT, Pujade-Lauraine E. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. Int J Gynecol Cancer. 2022, 32:1531-9. 10.1136\/ijgc-2022-003801","journal-title":"Int J Gynecol Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in women with low-risk cervical cancer","volume":"390","author":"Plante M","year":"2024","unstructured":"Plante M, Kwon JS, Ferguson S, et al.. Simple versus radical hysterectomy in women with low-risk cervical cancer. N Engl J Med. 2024, 390:819-29. 10.1056\/NEJMoa2308900","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino J","year":"2020","unstructured":"Chino J, Annunziata CM, Beriwal S, et al.. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020, 10:220-34. 10.1016\/j.prro.2020.04.002","journal-title":"Pract Radiat Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez PT","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, et al.. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018, 379:1895-904. 10.1056\/NEJMoa1806395","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e34","article-title":"Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update","volume":"28","author":"Landoni F","year":"2017","unstructured":"Landoni F, Colombo A, Milani R, Placa F, Zanagnolo V, Mangioni C. Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update. J Gynecol Oncol. 2017, 28:e34. 10.3802\/jgo.2017.28.e34","journal-title":"J Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - update 2023","volume":"33","author":"Cibula D","year":"2023","unstructured":"Cibula D, Raspollini MR, Planchamp F, et al.. ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - update 2023. Int J Gynecol Cancer. 2023, 33:649-66. 10.1136\/ijgc-2023-004429","journal-title":"Int J Gynecol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis A","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999, 73:177-83. 10.1006\/gyno.1999.5387","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta S","year":"2018","unstructured":"Gupta S, Maheshwari A, Parab P, et al.. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol. 2018, 36:1548-55. 10.1200\/JCO.2017.75.9985","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02852","article-title":"Randomized Phase III study comparing neoadjuvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994","volume":"41","author":"Kenter GG","year":"2023","unstructured":"Kenter GG, Greggi S, Vergote I, et al.. Randomized Phase III study comparing neoadjuvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994. J Clin Oncol. 2023, 41:5035-43. 10.1200\/JCO.22.02852","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0b013e31826e4609","article-title":"Cervical carcinoma rates among young females in the United States","volume":"120","author":"Benard VB","year":"2012","unstructured":"Benard VB, Watson M, Castle PE, Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012, 120:1117-23. 10.1097\/aog.0b013e31826e4609","journal-title":"Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa107","article-title":"A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan","volume":"62","author":"Kaneyasu Y","year":"2021","unstructured":"Kaneyasu Y, Fujiwara H, Nishimura T, et al.. A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan. J Radiat Res. 2021, 62:269-84. 10.1093\/jrr\/rraa107","journal-title":"J Radiat Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040777","article-title":"Quality of life in cervical cancer survivors treated with concurrent chemoradiotherapy","volume":"59","author":"Stuopelyt\u0117 R","year":"2023","unstructured":"Stuopelyt\u0117 R, \u017dukien\u0117 G, Breivien\u0117 R, Rudaitis V, Bartkevi\u010dien\u0117 D. Quality of life in cervical cancer survivors treated with concurrent chemoradiotherapy. Medicina (Kaunas). 2023, 59:777. 10.3390\/medicina59040777","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66661-y","article-title":"The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China","volume":"10","author":"Yang L","year":"2020","unstructured":"Yang L, Yuan J, Zeng X, Xi M, Wang H. The outcomes and quality of life of young patients undergoing adjuvant radiotherapy versus non-radiotherapy following surgery treating early FIGO stage cervical squamous cell cancer in southwestern China. Sci Rep. 2020, 10:9583. 10.1038\/s41598-020-66661-y","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson NK","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al.. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85:365-76. 10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22217","article-title":"The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24","volume":"107","author":"Greimel ER","year":"2006","unstructured":"Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, et al.. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006, 107:1812-22. 10.1002\/cncr.22217","journal-title":"Cancer"},{"key":"ref17","unstructured":"The EORTC quality of life questionnaires. Accessed. January 2, 2024: https:\/\/qol.eortc.org\/questionnaires\/."},{"key":"ref18","unstructured":"EORTC QLQ-C30 scoring manual. Accessed. April 1, 2024: https:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf."},{"key":"ref19","unstructured":"EORTC QLQ-CX24 scoring manual. Accessed. April 1, 2024: https:\/\/www.eortc.be\/qol\/ScoringInstructions\/CX24%20Summary.pdf."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.3996","article-title":"Quality of life and sexual functioning in cervical cancer survivors","volume":"23","author":"Frumovitz M","year":"2005","unstructured":"Frumovitz M, Sun CC, Schover LR, et al.. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005, 23:7428-36. 10.1200\/JCO.2004.00.3996","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1426","article-title":"Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study","volume":"18","author":"Greimel ER","year":"2009","unstructured":"Greimel ER, Winter R, Kapp KS, Haas J. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009, 18:476-82. 10.1002\/pon.1426","journal-title":"Psychooncology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000880","article-title":"Long-term morbidity and quality of life in cervical cancer survivors: a multicenter comparison between surgery and radiotherapy as primary treatment","volume":"27","author":"Derks M","year":"2017","unstructured":"Derks M, van Lonkhuijzen LR, Bakker RM, et al.. Long-term morbidity and quality of life in cervical cancer survivors: a multicenter comparison between surgery and radiotherapy as primary treatment. Int J Gynecol Cancer. 2017, 27:350-6. 10.1097\/IGC.0000000000000880","journal-title":"Int J Gynecol Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.2.385","article-title":"Quality of life in cervical cancer survivors and healthy women: Thai urban population study","volume":"18","author":"Prasongvej P","year":"2017","unstructured":"Prasongvej P, Nanthakomon T, Jaisin K, et al.. Quality of life in cervical cancer survivors and healthy women: Thai urban population study. Asian Pac J Cancer Prev. 2017, 18:385-9. 10.22034\/APJCP.2017.18.2.385","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043751","article-title":"Impact of cervical cancer on quality of life and sexuality in female survivors","volume":"20","author":"Membrilla-Beltran L","year":"2023","unstructured":"Membrilla-Beltran L, Cardona D, Camara-Roca L, Aparicio-Mota A, Roman P, Rueda-Ruzafa L. Impact of cervical cancer on quality of life and sexuality in female survivors. Int J Environ Res Public Health. 2023, 20:3751. 10.3390\/ijerph20043751","journal-title":"Int J Environ Res Public Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman M","year":"2006","unstructured":"Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006, 65:169-76. 10.1016\/j.ijrobp.2005.10.019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30389-4","article-title":"Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study","volume":"20","author":"H\u00f6ckel M","year":"2019","unstructured":"H\u00f6ckel M, Wolf B, Schmidt K, et al.. Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study. Lancet Oncol. 2019, 20:1316-26. 10.1016\/S1470-2045(19)30389-4","journal-title":"Lancet Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.01.014","article-title":"Role of adjuvant therapy in intermediate-risk cervical cancer patients - subanalyses of the SCCAN study","volume":"170","author":"Cibula D","year":"2023","unstructured":"Cibula D, Akilli H, Jarkovsky J, et al.. Role of adjuvant therapy in intermediate-risk cervical cancer patients - subanalyses of the SCCAN study. Gynecol Oncol. 2023, 170:195-202. 10.1016\/j.ygyno.2023.01.014","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290043-impact-of-various-treatment-modalities-on-long-term-quality-of-life-in-cervical-cancer-survivors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:59:47Z","timestamp":1725458387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290043-impact-of-various-treatment-modalities-on-long-term-quality-of-life-in-cervical-cancer-survivors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.68642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}